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Fatigue in hemodialysis patients
While HD per se is a life saving procedure, 
it cannot substitute for a healthy kidney, 
it taxes the patient and HD related fatigue 
symptoms significantly affect patients’ 
quality and way of life as suggested by 
many (McCann and Boore, 2000; Caplin 
et al., 2011; Gordon et al., 2011; Jhamb 
et al., 2011). Muscle status is gravely 
affected with HD patients demonstrating 
severe atrophy, fat infiltration, and other 
anomalies (Sakkas et al., 2008b). Overall, 
HD patients exhibit low levels of physical 
activity and functional capacity while they 
suffer from generalized weakness, exercise 
intolerance, and muscle atrophy, all leading 
to generalized sense of fatigue (Johansen 
and Painter, 2012). The causes of fatigue 
in HD patients are not well understood but 
it is been shown that these should include 
both muscular and central activation fail-
ures (Johansen et al., 2005).
Moreover, correction of anemia (Jhamb 
et al., 2011), exercise training (Koufaki 
et al., 2002; Sakkas et al., 2003b) with or 
without anabolic steroid (Johansen et al., 
2006), and/or nutritional supplements 
(Kalantar-Zadeh et al., 2011) do improve 
the clinical condition of the HD patients, 
however, despite such improvements, we 
have observed that HD patients’ functional 
capacity cannot equal that of a sedentary 
aged matched healthy counterpart.
A cause of the observed minimal levels 
of physical activity is probably that the HD 
procedure per se [e.g., duration of dialysis 
sessions (Caplin et al., 2011) etc.,] contrib-
utes to fatigue. One third of the patients 
report that they feel worse in the immediate 
hours after the dialysis session while one 
out of four reports severe or very severe 
intensity of fatigue after dialysis (Gordon 
et al., 2011). The severity of “Post-dialysis 
Moreover, patients present with sleep prob-
lems (Sakkas et al., 2008a), neurological and 
quality of life issues (Giannaki et al., 2011), 
anxiety, and/or symptoms of depression but 
most notably they complain of chronic 
fatigue and “lack of energy” (McCann and 
Boore, 2000).
What is Fatigue?
The traditional approach in identifying, 
researching, and assessing signs of fatigue 
has a dual nature: central vs. peripheral, 
brain vs. muscle, physical vs. mental etc.
Mental fatigue is a psychobiological 
state caused by prolonged and intensive 
cognitive activity and is expressed by the 
lack of concentration and the inability of 
staying focused under certain conditions 
(Marcora et al., 2009). Physical (muscle) 
fatigue on the other hand is accepted 
mainly as an inability to exert or sustain 
muscle force or power output for a given 
task (Edwards, 1975). Moreover, there is 
heated discussion in the literature on the 
origins and modulation of physical fatigue 
(Shephard, 2009; Noakes, 2011a,b), beyond 
the scope of this article.
Likewise in chronic disease patients, it is 
been suggested that the symptoms of fatigue 
relate to two components: the mental that 
encompasses emotional and cognitive qual-
ities and the physical, encompassing sleepi-
ness, lack of energy, and muscle weakness 
(Hardy and Studenski, 2010).
How we view fatigue is of course impor-
tant as it dictates how we identify signs, how 
we interpret or link symptoms and how we 
implement rehabilitation interventions and 
overall patient care. We can conclude that 
“fatigue is the inability of sustaining an effort 
either mentally or physically or both while 
signs and symptoms may be interconnected 
in a way not always clearly defined.”
introduction
In this opinion article we discuss whether 
fatigue symptoms and signs often noticed 
in the hemodialysis (HD) patients should 
be collectively viewed and addressed as a 
“syndrome” and not in usual polarities such 
as peripheral vs. central fatigue, or, physical 
vs. mental fatigue etc. Our rationale follows 
the example of “Chronic Fatigue Syndrome 
(CFS)” to help us substantiate our argu-
ment. It is important to stress that “Sign” 
and “Symptom” are terms with different 
meanings; symptoms are problems that a 
patient perceives while signs are whatever 
features an observer can objectively detect 
or measure. In practice a syndrome com-
bines symptoms, signs, and phenomena 
that the health practitioner recognizes, 
being alerted in that if some are observed 
then more are expected. In the case of what 
is being increasingly described as “HD 
fatigue” symptoms and signs may not have 
a very clear association resulting in ineffec-
tive or no action to remedy, partly because 
we have not yet identified/labeled them, as 
a scientific or health care community, as a 
group, i.e., as a syndrome.
Chronic renal disease is a “silent epi-
demic” affecting up to 10% of the popula-
tion in the USA, and Asian countries, with 
some sufferers progressing in to end-stage 
renal failure (Stenvinkel, 2010). Renal 
disease patients are characterized by pro-
gressively worsening muscle weakness and 
muscle atrophy due to both a metabolic and 
a disuse component collectively described 
as uremic myopathy. While various inter-
ventions in stable HD patients have helped 
these patients improve their functionality, 
they still have not proven enough to bring 
their muscle quality and quantity up to 
the levels of a healthy sedentary person 
(Sakkas et al., 2003b; Johansen et al., 2006). 
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Fatigue” symptoms could range from mild 
to severe and can last from a few hours after 
the dialysis procedure up to until the next 
day (Lindsay et al., 2006) or for a “very long 
time” (Gordon et al., 2011). Thus many 
HD patients may spent a large proportion 
of their time in a state of fatigue (Caplin 
et al., 2011; Gordon et al., 2011), and since 
they perceive fatigue (whether in dialysis 
or in non-dialysis days) as an important 
barrier (Delgado and Johansen, 2012), 
this adversely affects their physical activity 
levels.
Other factors that contribute to the 
excessive fatigue area lack of restorative 
sleep (Sakkas et al., 2008b), excess pre-
dialysis weight (Sklar et al., 1999), poor 
nutritional status (Jhamb et al., 2011), 
restless legs syndrome (Giannaki et al., 
2011), and the overall mental status of the 
patients (Jhamb et al., 2011). Evidently, 
of all of these factors can contribute to a 
self-exacerbating process, a vicious circle, 
of fatigue due to inactivity and further 
inactivity due to fatigue. This sensation 
of an enduring fatigue interferes with 
physical and social activities and feeds 
perceptions of increased restrictions and 
barriers (Delgado and Johansen, 2012), 
and leads to a significant reduction of 
physical activity and functional capacity, 
which in turn contributes to the increased 
cardiovascular risk and a high mortality 
rate among these patients (Sarnak et al., 
2003).
The state of current knowledge regarding 
the differences between generalized fatigue 
and HD treatment related fatigue is not well 
understood however many variables have 
been implicated in the severity and the prev-
alence of the symptoms. The variables can 
be divided into: (a) social and demographic 
including age, dialysis vintage, gender, and 
race, (b) clinical variables including anemia, 
anorexia, nutritional status, chronic inflam-
mation, sleep disorders, physical inactivity, 
comorbidities, and depression, and (c) 
some laboratory variables including Kt/V, 
serum creatinine and urea, and levels of 
parathyroid hormone (Bossola et al., 2011). 
The etiology of fatigue in HD patients is not 
a simple “one stop” investigation. It involves 
many aspects of patients’ health as well as 
various social and behavioral factors that 
depend on patients’ health characteristics 
and mental attitude (McCann and Boore, 
2000).
What We can learn From chronic 
Fatigue
A disorder called “CFS” is generally defined 
by persistent mental and physical fatigue 
accompanied by other specific symptoms 
(Arnett et al., 2011). While its causes are 
undefined, it is managed as a syndrome 
(given some accepted “operational” diag-
nostic criteria; Wessely, 2001) and sufferers 
are offered multidisciplinary care.
Patients on maintenance HD therapy 
share many similarities to those suffering 
by CFS since they experience generalized 
weakness (Johansen et al., 2003), exercise 
in tolerance (Koufaki et al., 2002), and dis-
turbed sleep (Sakkas et al., 2008a) all leading 
to a sense of generalized fatigue and “lack 
of energy” (McCann and Boore, 2000; 
Kovacs et al., 2011). This chronic state of 
“HD Fatigue” among HD patients satisfies 
one major requirement for the diagnosis 
of CFS which is persistent fatigue pre-
sent at least during 50% of the time over 
a period of at least 6 months (Jason et al., 
2003). However, as renal failure is present, 
the second requirement for the diagnosis 
of CFS, which is the absence of disease, is 
contradicted. So far the single symptom 
approach of fatigue in HD patients did not 
succeed to ameliorate patients’ sense of 
fatigue (Letchmi et al., 2011) and therefore, 
by viewing signs and symptoms of fatigue 
in a holistic approach would at least allow 
practitioners and scientists to address the 
problem as efficiently as in CFS patients. 
Such an approach will be challenging, given 
the variety in intensity and the causes of 
these symptoms, but not impossible, and 
can hold large benefits to the patients’ qual-
ity of life as the CFS treatments have shown 
so far in other populations.
hypothesis oF “hemodialysis 
Fatigue syndrome”
The prevalence of general undefined 
fatigue in HD patients ranges from 30 to 
80% depending on the assessment tools 
and the dialysis modality (Bossola et al., 
2011). The average score of fatigue in HD 
patients is the worst of all chronic disease 
patients (Ware et al., 1993) including those 
with severe depression (Yatham et al., 2004), 
cancer patients undergoing chemotherapy 
(Adamsen et al., 2009), and lupus patients 
(Jolly, 2005). In addition, the majority of 
HD patients complain of various “non-
specific” symptoms that are very often 
considered by their health care providers 
as “irrelevant” to fatigue. However, if those 
“irrelevant” symptoms (see below) could be 
seen under the prism of a “syndrome” (as in 
the case of CFS), it is possible that the final 
diagnosis and treatment of symptomatol-
ogy would be much different.
For example, in the diagnosis of CFS, 
various complementary criteria play an 
important role in the final decision such as 
pain in multiple joints, headaches, nausea, 
chest pain, shortness of breath, difficulties 
in maintaining upright position, and vari-
ous psychological problems such as depres-
sion, irritability, mood swings, and other 
(Burton et al., 2009). Those are evident in 
HD patients however, the clinical signifi-
cance of those symptoms changes when 
viewed in relation to fatigue.
The realization of any physical activity 
requires an efferent action to recruit the 
proper number of motor units in the active 
muscles. At the beginning of the activity, the 
extent of muscle recruitment will depend 
mostly on the physical health of the person 
(Hettinga et al., 2011), the mental and emo-
tional health, the extent of mental fatigue 
(Marcora et al., 2009), the level of sleep dep-
rivation (Skein et al., 2011), the quality of 
rest, and recovery from a previous activities 
(Eston et al., 2007) as well as the level of 
motivation and self-esteem (Micklewright 
et al., 2010).
Hypothetically, when the same consid-
eration applies to a HD patient, one should 
consider that a lower number of motor neu-
rons would be activated due to uremic neu-
ropathy (Krishnan and Kiernan, 2007), that 
the HD patient may be experiencing muscle 
atrophy and/or fat infiltration (Sakkas et al., 
2003a, 2008b; thus will be weaker than an 
aged matched control), in addition to vari-
ous emotional and mental distresses that 
seem to affect the level of exercise toler-
ance (Kouidi et al., 2010). Furthermore, 
the majority of HD patients complain of 
“brain fog” and lethargy (Caplin et al., 2011) 
especially in the hours post dialysis (Tryc 
et al., 2011), while one out of two have very 
low quality of sleep and suffer from daily 
sleepiness (Sakkas et al., 2008a; Giannaki 
et al., 2011). Moreover, the HD procedure 
per se filters away many small molecules 
involved in metabolism (glucose, amino 
acids, minerals, hormones etc.) leaving the 
patient feeling drained and exhausted, with 
inadequate time to recover, since the next 
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rewarding for patients, health care provid-
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Future research needs to focus on clini-
cal and functional examination of those HD 
patients with severe and persistent fatigue vs. 
those with no or minimal signs and symp-
toms and clarifying whether or not HD 
Fatigue may be “equivalent” to CFS. This 
could lead to better care for HD patients.
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